Publikationen der AG


Prof. Dr. med. Dr. h. c. Wolfgang Rascher

Veröffentlichte Artikel

Schellinger IN, Cordasic N, Panesar J, Jacobi J, Hartner A, Klanke B, Buchholz B, Burzlaff N, Warnecke C, Willam C, Tsao PS, Eckardt KU, Amann K, Hilgers KF (2016): HIF stabilization via carbone monoxide and pharmacological inhibition of prolyl-4-hydroxylase improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease. Kidney Int, in press

Knieling F, Strobel D, Rompel O, Zapke M, Menendez-Castro C, Wölfel M, Schulz J, Rascher W, Jüngert J (2016): Spectrum, applicability and diagnostic capacity of contrast-enhanced ultrasound in pediatric patients and young adults after intravenous application - A retrospective trial. Ultraschall Med, in press

Hartner A, Jagusch L, Cordasic N, Amann K, Veelken R, Jacobi J, Hilgers KF (2016): Impaired neovascularization and reduced capillary supply in the malignant versus non-malignant course of experimental renovascular hypertension. Front Physiol 7, 370

Marek I, Lichtneger T, Cordasic N, Hilgers KF, Volkert G, Fahlbusch F, Rascher W, Hartner A, Menendez-Castro C (2016): Alpha8 integrin signalling attenuates chronic renal interstitial fibrosis by reducing fibroblast activation, not by interfering with the regulation of cell turnover. PLoS One 11, e0150471

Heussner K, Ruebner M, Huebner H, Rascher W, Menendez-Castro C, Hartner A, Fahlbusch FB, Rauh M (2016): Species differences of 11beta-hydroxysteroid dehydrogenase type 2 function in human and rat term placenta determined via LC-MS/MS. Placenta 37, 79-84

Fahlbusch FB, Ruebner M, Huebner H, Volkert G, Bartunik H, Winterfeld I, Hartner A, Menendez-Castro C, Noegel SC, Marek I, Wachter D, Schneider-Stock R, Beckmann MW, Kehl S, Rascher W (2015): Placental characterization of the tumor-suppressor gene gastrokine-2. Histochem Cell Biol 144, 281-291

Fahlbusch FB, Heussner K, Schmid M, Schild R, Ruebner M, Huebner H, Rascher W, Doerr HG, Rauh M (2015): Measurement of amniotic fluid steroids of midgestation via LC-MS/MS. J Steroid Biochem Mol Biol 152, 155-160

Benderska N, Dittrich AL, Knaup S, Rau TT, Neufert C, Wach S, Fahlbusch FB, Rauh M, Wirtz RM, Agaimy A, Srinivasan S, Mahadevan V, Rümmele P, Rapti E, Gazouli M, Hartmann A, Schneider-Stock R (2015): miRNA-26b overexpression in ulcerative colitis-associated carcinogenesis. Inflamm Bowel Dis 21, 2039-2051

Marek I, Benz K, Kusnik S, Morhart P, Botzenhardt S, Toni I, Rascher W (2015): Phosphate intoxication after application of enema – a life-threatening iatrogenic complication. Klin Pädiatr 227, 235-238

Fahlbusch FB, Hartner A, Menendez-Castro C, Noegel SC, Beckmann MW, Schleussner E, Ruebner M, Huebner H, Dörr HG, Schild RL, Dötsch J, Rascher W (2015): The placental mTOR pathway: biomarker for early growth trajectories following intrauterine growth restriction? J Dev Origins Health Dis 6, 317-326

Menendez-Castro C, Cordasic N, Neureiter D, Amann K, Marek I, Volkert G, Stintzing S, Jahn A, Rascher W, Hilgers KF, Hartner A (2015): Underexpression of alpha8 integrin aggravates experimental atherosclerosis. J Pathol 236, 5-16

El-Baba C, Mahadevan V, Fahlbusch FB, S SM, Rau TT, Gali-Muhtasib H, Schneider-Stock R (2014): Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer. Mol Cancer 29;13:201.

Beinder L, Fährmann N, Wachtveitl R, Winterfeld I, Hartner A, Menendez-Castro C, Rauh M, Ruebner M, Huebner H, Noegel SC, Doerr HG, Rascher W, Fahlbusch F (2014): Detection of expressional changes induced by intrauterine growth restriction in the developing rat mammary gland via exploratory pathways analysis. PLoS One 9, e100504

Marek I, Volkert G, Hilgers KF, Bieritz B, Reinhardt DP, Rascher W, Hartner A (2014): Fibrillin-1 and alpha8 integrin are co-expressed in the glomerulus and interact to convey adhesion of mesangial cells. Cell Adhes Migrat 8, 389-395

Menendez-Castro C, Toka O, Fahlbusch F, Cordasic N, Wachtveitl R, Rascher W, Hilgers KF, Hartner A (2014): Impaired myocardial performance in a normotensive rat model of intrauterine growth restriction. Ped Research 75, 697-706

Volkert G, Jahn A, Dinkel C, Fahlbusch F, Zürn C, Hilgers KF, Rascher W, Hartner A, Marek I (2014): Contribution of alpha8 integrin to the expression of extracellular matrix components. Cell Commun Adhes 21, 89-98

Hartner A, Cordasic N, Klanke B, Menendez-Castro C, Veelken R, Schmieder RE, Hilgers KF (2014): Renal protection by low dose irbesartan in diabetic nephropathy is paralleled by a reduction of inflammation, not of ER stress. BBA - Mol Basis Dis 1842, 558-565

Fahlbusch F, Ruebner M, Huebner H, Volkert G, Zuern C, Thiel F, Koch M, Menendez-Castro C, Wachter DL, Hartner A, Rascher W: The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration. Placenta 2013, 34:1027-35
Ruebner M, Strissel P, Ekici AB, Stiegler E, Dammer U, Goecke TW, Faschingbauer F, Fahlbusch F, Beckmann MW, Strick R: Reduced syncytin-1 expression levels in placental syndromes correlates with epigenetic hypermethylation of the ERVW-1 promoter region. PLoS One 2013, 8:e56145
Fahlbusch F, Ruebner M, Rascher W, Rauh M: Combined quantification of corticotropin-releasing hormone, cortisol-to-cortisone ratio and progesterone by liquid chromatography-Tandem mass spectrometry in placental tissue. Steroids 2013, 78:888-95
Menendez-Castro C, Hilgers KF, Amann K, Cordasic N, Wachtveitl R, Fahlbusch F, Plank C, Dötsch J, Rascher W, Hartner A: Intrauterine growth restriction leads to a dysregulation of WT1 and to early podocyte alterations. Nephrol Dial Transplant 2013, 28:1407-17

Hartner A, Menendez-Castro C, Cordasic N, Marek I, Volkert G, Klanke B, Rascher W, Hilgers KF: Tubulointerstitial de novo expression of the alpha8 integrin chain in renal fibrosis – A potential target for anti-fibrotic therapy? PLoS One 2012, 7:48362
Fahlbusch FB, Ruebner M, Volkert G, Offergeld R, Hartner A, Menendez-Castro C, Strick R, Rauh M, Rascher W, Dötsch J: Corticotropin-releasing hormone stimulates expression of leptin, 11beta-HSD2 and syncytin-1 in primary human trophoblasts, Reprod Biol Endocrinol 2010, 10:80
Fahlbusch FB, Dawood Y, Hartner A, Menendez-Castro C, Nögel SC, Tzschoppe A, Schneider H, Strissel P, Beckmann MW, Schleussner E, Ruebner M, Dörr H, Schild R, Rascher W, Doetsch J: Cullin 7 and Fbxw 8 expression in trophoblastic cells is regulated via oxygen tension: implications for intra-uterine growth restriction? J Matern Fetal Neonatal Med 2012, 25:2209-15
Menendez-Castro C, Cordasic N, Schmid M, Fahlbusch F, Rascher W, Amann K, Hilgers KF, Hartner A: Intrauterine growth restriction promotes atherosclerotic vascular remodelling following carotid artery ligation in rats, Clin Sci 2012, 123:437-444
Amann K, Haas CS, Schüssler J, Daniel C, Hartner A, Schöcklmann HO: Beneficial effects of integrin alphavbeta1-blocking RGD peptides in early but not late phase of experimental glomerulonephritis. Nephrol Dial Transplant 2012, 27:1755-1768

Benz K, Campean V, Cordasic N, Karpe B, Neuhuber W, Mall G, Hartner A, Hilgers KF, Amann K: Early glomerular alterations in genetically determined low nephron number. Am J Physiol Renal Physiol 2011, 300:F521-F530
Amann K, Odoni G, Benz K, Campean V, Jacobi J, Hilgers KF, Hartner A, Veelken R, Orth S: Sympathetic blockade prevents the decrease in cardiac VEGF expression and capillary supply in experimental renal failure. Am J Physiol Renal Physiol 2011, 300:F105-F112
Fujiwara H, Ferreira M, Donati G, Marciano DK, Linton JM, Sato Y, Hartner A, Sekiguchi K, Reichardt LF, Watt FM: The basement membrane of hair follicle stem cells is a muscle cell niche: Wnt-dependent nephronectin deposition. Cell 2011, 144:77-589
Alejandre Alcázar M, Boehler E, Amann K, Klaffenbach D, Hartner A, Allabauer I, Wagner L, von Hörsten S, Plank C, Dötsch J: Persistent changes within the intrinsic kidney-associated NPY-system and tubular function by litter size reduction. Nephrol Dial Transplant 2011, 26:2453-2465
Menendez-Castro C, Fahlbusch F, Cordasic N, Amann K, Münzel K, Plank C, Wachtveitl R, Rascher W, Hilgers KF, Hartner A: Early and late postnatal myocardial and vascular changes in a protein restriction rat model of intrauterine growth restriction. PLoS One 2011, 6:e20369
Knier B, Cordasic N, Klanke B, Heusinger-Ribeiro J, Daniel C, Veelken R, Hartner A, Hilgers KF: Role of the plasminogen-plasmin-system in hypertensive organ damage. J Hypertens 2011, 29:1602-1612
Klaffenbach D, Meissner U, Raake M, Fahlbusch F, Alejandre Alcazar MA, Allabauer I, Kratzsch J, Rascher W, Dötsch J: Upregulation of leptin-receptor in placental cells by hypoxia. Regul Pept 2011, 167:156-62
Tzschoppe A, Fahlbusch F, Seidel J, Dörr HG, Rascher W, Goecke TW, Beckmann MW, Schild RL, Struwe E, Dötsch J: Dexamethasone stimulates the expression of leptin and 11β-HSD2 in primary human placental trophoblastic cells. Eur J Obstet Gynecol Reprod Biol 2011, 156:50-5

Westhoff JH, Schildhorn C, Jacobi C, Hömme M, Hartner A, Braun H, Kryzer C, Wang C, von Zglinicki T, Kränzlin B, Gretz N, Melk A: Telomere Shortening Reduces Regenerative Capacity after Acute Kidney Injury. J Am Soc Nephrol 2010, 21:327-336
Geissler B, Plank C, Hartner A, Amann K, Struwe FG, Hilgers KF, Rascher W, Dötsch J. Effects of adrenomedullin on the glomerular adrenomedullin system in a rat model of Anti-Thy1.1 nephritis. Nephron Exp Nephrol 2010, 115:e80-88
Plank C, Nüsken K, Menendez-Castro C, Hartner A, Östreicher I, Amann K, Baumann P, Peters H, Rascher W, Dötsch J: Intrauterine growth restriction following ligation of the uterine arteries leads to more severe glomerulosclerosis after mesangioproliferative glomerulonephritis in the offspring. Am J Nephrol 2010, 32:287-295
Hartner A, Cordasic N, Menendez-Castro C, Volkert G, Yabu JM, Kupraszewicz-Hutzler M, Rascher W, Hilgers KF: Lack of alpha8 integrin aggravates podocyte injury in experimental diabetic nephropathy. Am J Physiol Renal Physiol 2010, 299:F1151-7
Marek I, Volkert G, Jahn A, Fahlbusch F, Zürn C, Özcan Z, Goppelt-Strübe M, Hilgers KF, Rascher W, Hartner A: Lack of alpha8 integrin leads to morphological changes in renal mesangial cells, but not in vascular smooth muscle cells. BMC Cell Biology 2010, 11:102
Ruebner M, Strissel PL, Langbein M, Fahlbusch F, Wachter DL, Faschingbauer F, Beckmann MW, Strick R: Impaired cell fusion and differentiation in placentae from patients with intrauterine growth restriction correlate with reduced levels of HERV envelope genes. J Mol Med (Berl) 2010; 88:1143-56

Hartner A, Cordasic N, Rascher W, Hilgers KF: Deletion of the alpha8 integrin gene does not protect mice from myocardial fibrosis in DOCA hypertension. Am J Hypertens 2009, 22:92-9
Hartner A, Klanke B, Cordasic N, Amann K, Schmieder RE, Veelken R, Hilgers KF: Statin treatment reduces glomerular inflammation and podocyte damage in rat DOCA-salt hypertension. J Hypertens 2009, 27:376-85
Amann K, Haas CS, Zeiler G, Benz K, Bader BL, Hartner A, Hilgers KF: Lack of nidogen-2 increases blood pressure, glomerular and tubulointerstitial damage in DOCA-salt hypertension. Eur J Clin Invest 2009, 39:116-25
Stintzing S, Ocker M, Hartner A, Amann K, Letterio B, Neureiter D: Differentiation patterning of vascular smooth muscle cells (VSMC) in atherosclerosis. Virchow’s Archiv 2009, 455:171-85
Krüger B, Härteis S, Yang L, Hartner A, Rauh R, Korbmacher C, Diakov A: Cholesterol depletion of the plasma membrane prevents activation of the epithelial sodium chanel (ENaC) by SGK-1. J Cell Physiol Biochem 2009, 24:605-618
Tzschoppe A, Struwe E, Blessing H, Fahlbusch F, Liebhaber G, Dörr HG, Rauh M, Rascher W, Goecke TW, Schild RL, Schleussner E, Scheler C, Hübler A, Dahlem P, Dötsch J: Placental 11beta-HSD2 gene expression at birth is inversely correlated with growth velocity in the first year of life after intrauterine growth restriction. Pediatr Res 2009;65:647-53

Hartner A, Marek I, Cordasic N, Haas C, Schöcklmann HO, Hülsmann-Volkert G, Plasa I, Rascher W, Hilgers KF, Amann K: Glomerular regeneration is delayed in nephritic α8 integrin-deficient mice: Contribution of α8 integrin to the regulation of mesangial cell apoptosis. Am J Nephrol 2008, 28:168-178
Zeltner R, Hilgers KF, Schmieder RE, Porst M, Schulze BD, Hartner A: A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal dominant polycystic kidney disease, Nephron Clin Pract 2008, 108:169-175
Bertog M, Cuffe JE, Hummler E, Hartner A, Porst M, Hilgers KF, Rossier BC, Korbmacher C: The gain of aldosterone to stimulate ENaC mediated Na+ transport in colon is increased in a mouse model for Liddle’s syndrome. J Physiol 2008, 586:459-475
Müller DN, Klanke B, Feldt S, Cordasic N, Hartner A, Schmieder RE, Luft FC, Hilgers FC: (Pro)renin receptor peptide inhibitor “handle-region” peptide does not affect hypertensive nephrosclerosis in Goldblatt rats. Hypertension 2008, 51:676-681
Veelken R, Hilgers KF, Vogel E, Amann K, Hartner A, Sass G, Neuhuber W, Tiegs G: Autonomic renal denervation ameliorates experimental glomerulonephritis in the rat. J Am Soc Nephrol 2008, 19:1371-8
Klanke B, Cordasic N, Hartner A, Schmieder RE, Veelken R, Hilgers KF: Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension. Nephrol Dial Transplant 2008, 23:3456-63
Westhoff JH, Hilgers KF, Steinbach MP, Hartner A, Klanke B, Amann K, Melk A: Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a. Hypertension 2008, 52:123-9
Spranger R, Hartner A, Schild RL, Knerr I, Rascher W, Dötsch J: Leptin expression in primary trophoblast cells is not increased by factors present in the preeclamptic maternal serum. Hypertens Pregnancy 2008, 27:267-77
Plank C, Grillhösl C, Östreicher I, Meißner U, Struwe FG, Rauh M, Hartner A, Rascher W, Dötsch J: Transient growth hormone therapy to rats with low protein-inflicted intrauterine growth restriction does not prevent elevated blood pressure later in life. Growth Factors 2008, 26:355-64

Hartner A, Cordasic N, Klanke B, Wittmann M, Veelken R, Hilgers KF: Renal injury in streptozotocin-diabetic Ren2-TGR rats is mainly dependent on hypertension, not on diabetes, Am J Physiol Renal Physiol 2007, 292:F820-827
Waschke J, Menendez-Castro C, Bruggeman P, Koob R, Amagai M, Gruber HJ, Drenckhahn D, Baumgartner W: Imaging and force spectroscopy on desmoglein 1 using atomic force microscopy reveal multivalent Ca(2+)-dependent, low-affinity trans-interaction. J Membr Biol. 2007, 216:83-92

Porst M, Plank C, Bieritz B, Konik E, Fees H, Dötsch J, Hilgers KF, Reinhardt DP, Hartner A: Fibrillin-1 regulates mesangial cell attachment, spreading, migration and proliferation. Kidney Int 2006, 69:450-6
Hartner A, Porst M, Klanke B, Cordasic N, Veelken R and Hilgers KF: Angiotensin II formation in the kidney contributes to nephrosclerosis in Ren-2 hypertensive rats. Nephrol Dial Transplant 2006, 21:1778-1785
Hartner A, Schaefer L, Porst M, Cordasic N, Gabriel A, Klanke B, Reinhardt DP, Hilgers KF: Role of fibrillin-1 in hypertensive and diabetic glomerular disease. Am J Physiol Renal Physiol 2006, 290:F1329-36
Plank C, Ostreicher I, Hartner A, Marek I, Struwe F, Amann K, Hilgers KF, Rascher W, Dötsch J: Intrauterine growth retardation aggravates the course of acute anti-Thy1.1-nephritis in the rat. Kidney Int 2006, 70:1974-1982
Ruan W, Fahlbusch F, Clemmons DR, Monaco ME, Walden PD, Silva AP, Schmid HA, Kleinberg DL: SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3? Mol Endocrinol. 2006, 20:426-36

Veelken R, Hilgers KF, Porst M, Krause H, Hartner A, Schmieder RE: Effects of sympathetic nerves and angiotensin II on renal sodium and water handling in rats with common bile duct ligature. Am J Physiol Renal Physiol 2005, 288:F1267-75
Hartner A, Veelken R, Wittmann M, Cordasic N, Hilgers KF: Effects of diabetes and hypertension on macrophage infiltration and matrix expansion in the rat kidney. BMC Nephrology 2005, 6:6
Plank C, Hartner A, Klanke B, Geissler B, Porst M, Amann K, Hilgers KF, Rascher W, Dötsch J: Adrenomedullin reduces mesangial cell number and glomerular inflammation in experimental mesangioproliferative glomerulonephritis. Kidney Int 2005, 68:1086-1095
Porst M, Daniel C, Plank C, Schocklmann HO, Reinhardt DP, Hartner A: Induction and coexpression of latent transforming growth factor beta-binding protein 1 (LTBP-1) and fibrillin-1 in experimental glomerulonephritis. Nephron (Exp Nephrol) 2005, 102:e99-e104

Hartner A, Eifert T, Haas CS, Tuysuz C, Hilgers KF, Reinhardt DP, Amann K: Characterization of the renal phenotype in a mouse model of Marfan Syndrome. Virchow’s Archiv 2004, 445:382-388
Hartner A, Hilgers KF, Bitzer M, Veelken R, Schöcklmann HO: Dynamic expression patterns of transforming growth factor-2 and transforming growth factor receptors in experimental glomerulonephritis. J Mol Med 2003, 81:32-42
Hartner A, Cordasic N, Goppelt-Struebe M, Veelken R, Hilgers KF: Role of macula densa cyclooxygenase-2 in renovascular hypertension. Am J Physiol Renal Physiol 2003, 284:F498-502
Gauer S, Hartner A, Hauser IA, Fierlbeck W, Eberhardt W, Geiger H: Differential regulation of osteopontin expression in the clipped and nonclipped kidney of two-kidney, one-clip hypertensive rats. Am J Hypertens 2003, 16:214-222
Bieritz B, Spessotto P, Colombatti A, Jahn A, Prols F, Hartner A: Role of 8 integrin in mesangial cell adhesion, migration and proliferation. Kidney Int 2003, 64:119-127
Hartner A, Cordasic N, Klanke B, Veelken R, Hilgers KF: Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate (DOCA)-salt in mice. Nephrol Dial Transplant 2003, 18:1999-2004
Haas CS, Amann K, Schittny J, Blaser B, Müller U, Hartner A: Glomerular and renal vascular structural changes in 8 integrin-deficient mice. J Am Soc Nephrol 2003, 14:2288-96
Hartner A, Cordasic N, Klanke B, Müller U, Sterzel RB, Hilgers KF: The alpha8 integrin chain affords mechanical stability to the glomerular capillary tuft in hypertensive glomerular disease. Am J Pathol 2002, 160:861-867
Mann B, Hartner A, Jensen BL, Hilgers KF, Höcherl K, Krämer BK, Kurtz A: Acute upregulation of COX-2 by renal artery stenosis. Am J Physiol Renal Physiol 2001, 280:F119-F125
Mann B, Hartner A, Jensen BL, Kammerl M, Krämer BK, Kurz A: Furosemide stimulates macula densa cyclooxygenase-2 expression in rats. Kidney Int 2001, 59:62-68
Hartner A, Porst M, Gauer S, Pröls F, Veelken R, Hilgers KF: Glomerular osteopontin expression and macrophage infiltration in glomerulosclerosis of DOCA-salt rats. Am J Kid Dis 2001, 38:153-164
Hilgers KF, Veelken R, Müller DN, Kohler H, Hartner A, Botkin SR, Stumpf C, Schmieder RE, Gomez RA: Renin uptake by the endothelium mediates vascular angiotensin formation. Hypertension 2001, 38:243-248
Porst M, Hartner A, Krause H, Hilgers KF, Veelken R: Inducible nitric oxide and glomerular hemodynamics in rats with liver cirrhosis. Am J Physiol Renal Physiol 2001, 281:293-299
Hilgers KF, Hartner A, Porst M, Veelken R, Mann JFE: Angiotensin II type 1 receptor blockade prevents lethal malignant hypertension: relation to kidney inflammation. Circulation 2001, 104:1436-1440
Veelken R, Hilgers KF, Hartner A, Haas A, Böhmer KP, Sterzel RB: Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol 2000, 11:71-79
Lang S, Hartner A, Sterzel RB, Schöcklmann HO: Requirement of cyclin D1 in mesangial cell mitogenesis. J Am Soc Nephrol 2000, 11:1398-1408
Hartner A, Pahl A, Brune K, Goppelt-Strübe M: Regulation of cyclooxygenases and the PGE2 receptor EP2 in rat and human mesangioproliferative glomerulonephritis. Inflamm Res 2000, 49:345-354
Schöcklmann HO, Lang S, Kralewski M, Hartner A, Lüdke A, Sterzel RB: Distinct structural forms of type I collagen modulate cell cycle regulatory proteins in mesangial cells. Kidney Int 2000 , 58:1108-20
Sterzel RB, Hartner A, Schlötzer-Schrehardt U, Voit S, Hausknecht B, Braghetta P, Doliana R, Colombatti A, Gibson MG, Bressan GM: Elastic fiber proteins in the glomerular mesangium in vivo and in cell culture. Kidney Int 2000, 58:1588-1602
Hilgers KF, Hartner A, Porst M, Mai M, Wittmann M, Hugo C, Ganten D, Geiger H, Veelken R, Mann JFE: Monocyte chemoattractant protein and monocyte/macrophage infiltration in hypertensive kidney injury. Kidney Int 2000, 58:2408-2419
Wolf K, Castrop H, Hartner A, Goppelt-Strübe M, Hilgers KF, Kurtz A: Inhibition of the renin-angiotensin system upregulates cyclooxygenase-2 expression in the macula densa. Hypertension 1999, 34:503-507
Hartner A, Schöcklmann HO, Pröls F, Müller U, Sterzel RB: Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis. Kidney Int 1999, 56:1468-1480
Hartner A, Goppelt-Strübe M, Hilgers KF: Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension. Hypertension 1998, 31:201-205
Hartner A, Goppelt-Strübe M, Hocke GM, Sterzel RB: Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M. Kidney Int 1997,51:1754-1760
Hartner A, Sterzel RB, Reindl N, Hocke GM, Fey GH, Goppelt-Strübe M: Cytokine-induced expression of leukemia inhibitory factor in renal mesangial cells. Kidney Int 1994, 45:1562-1571

Prof. Dr. rer. nat. Andrea Hartner
Bitte tragen Sie Ihren Namen und gültige E-Mail-Adresse(n) ein!
X zum Schließen